Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00005922 · ClinicalTrials.gov registry record · NA
Conditioning, the Placebo Effect, and Psoriasis
A NA study, sponsored by University of Rochester.
- Completed
- Registry status
- NA
- Development phase
- 138
- Enrollment target
NCT00005922 is a NA study that has completed, run by University of Rochester. The registered enrollment target is 138 participants.
The verdict
NCT00005922, a NA study, has completed, sponsored by University of Rochester.
- COMPLETED
- Registry status
- NA
- Development phase
- 138 participants
- Enrollment target
Study Summary
This study uses the psychological principle known as classical conditioning to try to improve the standard treatment of psoriasis. Classical conditioning is a process of behavioral modification in which a person learns to connect a certain response-in this case, improvement of psoriasis-with a new action, or stimulus-in this case, application of an inactive cream. The goal of this study is to show that people with psoriasis who are maintained on corticosteroid cream part of the time and an inactive (placebo) cream at other times show a lower incidence of relapse and a reduced severity of psoriasis that patients treated with that same (reduced) amount of medication administered all the time.
Interventions
- BEHAVIORAL Partial schedule of pharmacotherapeutic reinforcement
- DRUG Dose control for Arm B
- OTHER Standard pharmacotherapeutic protocol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 138 participants |
| Start Date | 2000-08 |
| Est. Completion | 2006-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00005922
The ClinicalTrials.gov registry entry for NCT00005922 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 138 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Rochester, which has 636 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Partial schedule of pharmacotherapeutic reinforcement is the first listed.
NCT00005922 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00005922 about?
NCT00005922 is a clinical study titled "Conditioning, the Placebo Effect, and Psoriasis". This study uses the psychological principle known as classical conditioning to try to improve the standard treatment of psoriasis. Classical conditioning is a process of behavioral modification in which a person learns to connect a certain response-in this case, improvement of psoriasis-with a new a...
What is the current status of trial NCT00005922?
This trial is currently completed. It is a NA study. The enrollment target is 138 participants. The study started on 2000-08. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00005922?
The interventions under investigation include: Partial schedule of pharmacotherapeutic reinforcement (BEHAVIORAL), Dose control for Arm B (DRUG), Standard pharmacotherapeutic protocol (OTHER).
Who is sponsoring clinical trial NCT00005922?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.